Key result
High PAWP at Impella weaning is linked to ~97% higher 30-day non-survival in cardiogenic shock.
Why the study?
Clinical predictors for successful weaning from Impella heart pump in patients with cardiogenic shock have not been clarified.
Do pulmonary artery catheter parameters at the time of Impella weaning predict 30-day outcomes in patients with cardiogenic shock?
Cohort (n=81)
Do pulmonary artery catheter parameters at the time of Impella weaning predict 30-day outcomes in patients with cardiogenic shock?
Hemodynamic assessment using PAC parameters (PAWP, MPAP, CPO) at the time of Impella weaning can effectively stratify the risk of 30-day mortality or need for mechanical circulatory support reintroduction in cardiogenic shock patients.
Answers are grounded in this paper and cite their sources.
Supports hemodynamic assessment at Impella weaning for risk stratification in cardiogenic shock; hypothesis-generating pending randomized validation.
BACKGROUND: Clinical predictors for successful weaning of patients from Impella heart pump have not been clarified. We aimed to elucidate the relationship between pulmonary artery catheter (PAC) parameters at the time of Impella weaning and subsequent outcomes. METHODS: We enrolled consecutive patients who had received Impella for cardiogenic shock. PAC data were collected immediately before Impella weaning. Patients were classified as non-survivors if they died or required any mechanical circulatory support reintroduction within 30 days of weaning. RESULTS: Of 81 patients enrolled, 61 underwent Impella weaning. Of these, 16 were non-survivors. Predictive indicators of non-survival were high pulmonary artery wedge pressure (PAWP; hazard ratio [HR] per 5 mm Hg 1.97, 95% CI 1.35-2.80; p < 0.001), high mean pulmonary artery pressure (MPAP; HR per 5 mm Hg 1.90, 1.38-2.58; p < 0.001), and low cardiac power output (CPO; HR per 0.1 Watts 0.71, 0.52-0.92; p = 0.006). Cutoff values of PAWP 20 mm Hg, MPAP 22 mm Hg, and CPO 0.59 Watts showed strong associations with 30-day non-survival risk (low risk 8% in patients with low PAWP and high CPO or 4% in patients with low MPAP and high CPO; high risk 100% in patients with high PAWP and low CPO or 82% in patients with high MPAP and low CPO). CONCLUSIONS: PAWP or MPAP higher than the cutoff with CPO below the cutoff at Impella weaning were associated with worse outcomes. We proposed a risk classification model for successful Impella weaning using PAC.
No takes yet. Share an insight, caveat, or question.
Ikeda et al. (2022) conducted a cohort in Cardiogenic shock (n=81). High pulmonary artery wedge pressure (PAWP) at Impella weaning vs. Low pulmonary artery wedge pressure was evaluated on Non-survival (death or requirement of any mechanical circulatory support reintroduction within 30 days of weaning) (HR 1.97, 95% CI 1.35-2.80, p=<0.001). High pulmonary artery wedge pressure (HR 1.97; 95% CI 1.35-2.80) at Impella weaning was strongly associated with 30-day non-survival in patients with cardiogenic shock.
Synapse has enriched 10 related papers. Consider them for comparative context: